Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine

V. Visconte, S. T. Nawrocki, C. M. Espitia, K. R. Kelly, A. Possemato, S. A. Beausoleil, Y. Han, H. E. Carraway, A. Nazha, A. S. Advani, J. P. Maciejewski, M. A. Sekeres, J. S. Carew

Research output: Contribution to journalArticle

10 Scopus citations
Original languageEnglish (US)
Publication statusAccepted/In press - Sep 15 2015

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this